Daniel J. Sargent
Impact in
- Oncology top 0.01%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Screening and Detection
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 262
- Colorectal Cancer Treatments and Studies 192
- Colorectal Cancer Surgical Treatments 70
- Cancer Treatment and Pharmacology 41
-
- Genetic factors in colorectal cancer 89
- Co-authors
- Richard M. Goldberg (141 shared papers)Larry Rubinstein (7 shared papers)Lawrence H. Schwartz (4 shared papers)Jan Bogaerts (6 shared papers)Lalitha Shankar (5 shared papers)Lori E. Dodd (4 shared papers)Janet Dancey (3 shared papers)Denis Lacombe (2 shared papers)
- Journals
- Journal of Clinical Oncology (186 papers)Clinical Cancer Research (20 papers)Cancer (15 papers)Annals of Oncology (14 papers)JNCI Journal of the National Cancer Institute (14 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Daniel J. Sargent
465 papers receiving 57.2k citations
Daniel J. Sargent's Hit Papers
Peers
Comparison fields: 5 of 198
- Oncology 26.0k
- Hepatology 4.3k
- Pathology and Forensic Medicine 7.7k
- Cancer Research 6.1k
- Pulmonary and Respiratory Medicine 10.6k
Countries citing papers authored by Daniel J. Sargent
This map shows the geographic impact of Daniel J. Sargent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Sargent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Sargent more than expected).
Fields of papers citing papers by Daniel J. Sargent
This network shows the impact of papers produced by Daniel J. Sargent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Sargent. The network helps show where Daniel J. Sargent may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel J. Sargent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 476 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) Hit paper breakdown → | 2008 | 21190 |
| 2 | Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial Hit paper breakdown → | 2012 | 2091 |
| 3 | A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer Hit paper breakdown → | 2003 | 1820 |
| 4 | Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer Hit paper breakdown → | 2003 | 1614 |
| 5 | Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer Hit paper breakdown → | 2010 | 1129 |
| 6 | Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy Hit paper breakdown → | 2009 | 1014 |
| 7 | Prognostic Factors in Colorectal Cancer Hit paper breakdown → | 2000 | 993 |
| 8 | Guidelines 2000 for Colon and Rectal Cancer Surgery Hit paper breakdown → | 2001 | 970 |
| 9 | Laparoscopic Colectomy for Cancer Is Not Inferior to Open Surgery Based on 5-Year Data From the COST Study Group Trial Hit paper breakdown → | 2007 | 838 |
| 10 | Survival of Patients With Advanced Colorectal Cancer Improves With the Availability of Fluorouracil-Leucovorin, Irinotecan, and Oxaliplatin in the Course of Treatment Hit paper breakdown → | 2004 | 828 |
| 11 | Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much? Hit paper breakdown → | 2004 | 759 |
| 12 | A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients Hit paper breakdown → | 2001 | 723 |
| 13 | Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials Hit paper breakdown → | 2005 | 523 |
| 14 | Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE) Hit paper breakdown → | 2008 | 520 |
| 15 | 2009 | 486 | |
| 16 | 2002 | 454 | |
| 17 | Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database Hit paper breakdown → | 2016 | 452 |
| 18 | 2009 | 423 | |
| 19 | Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841 Hit paper breakdown → | 2011 | 405 |
| 20 | DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy Hit paper breakdown → | 2011 | 404 |
About Daniel J. Sargent
Daniel J. Sargent is a scholar working on Oncology, Pathology and Forensic Medicine, Statistics and Probability, Cancer Research and Pulmonary and Respiratory Medicine, having authored 476 papers that have together received 58.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (192 papers), Statistical Methods in Clinical Trials (89 papers), Genetic factors in colorectal cancer (89 papers), Colorectal Cancer Surgical Treatments (70 papers), Cancer Genomics and Diagnostics (54 papers), Cancer Treatment and Pharmacology (41 papers), Gastric Cancer Management and Outcomes (33 papers) and Health Systems, Economic Evaluations, Quality of Life (29 papers). The work is most often cited by research in Oncology (26.0k citations), Hepatology (4.3k citations), Pathology and Forensic Medicine (7.7k citations), Cancer Research (6.1k citations) and Pulmonary and Respiratory Medicine (10.6k citations). Daniel J. Sargent has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Richard M. Goldberg, Larry Rubinstein, Lawrence H. Schwartz, Jan Bogaerts, Lalitha Shankar, Lori E. Dodd, Janet Dancey, Denis Lacombe, E. Eisenhauer and Stephen J. Gwyther. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer, Annals of Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.